Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 27 | $86,338,288 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
04 Aug 2023 19:32 | IMGN | ImmunoGen Inc | ENYEDY MARK J | CHIEF EXECUTIVE OFFICER | 02 Aug 2023 | Sale | 8,636 | 18.15 | 156,743 | D |
04 Aug 2023 19:32 | IMGN | ImmunoGen Inc | ENYEDY MARK J | CHIEF EXECUTIVE OFFICER | 02 Aug 2023 | Sale | 986,521 | 17.45 | 17,214,791 | D |
04 Aug 2023 19:33 | IMGN | ImmunoGen Inc | COEN STACY ANN | SVP & CHIEF BUSINESS OFFICER | 02 Aug 2023 | Sale | 4,255 | 18.12 | 77,101 | D |
04 Aug 2023 19:28 | IMGN | ImmunoGen Inc | LENTINI RENEE | PRIN. FIN & ACCTG. OFF. | 02 Aug 2023 | Sale | 148,277 | 17.55 | 2,602,261 | D |
04 Aug 2023 19:32 | IMGN | ImmunoGen Inc | ENYEDY MARK J | CHIEF EXECUTIVE OFFICER | 03 Aug 2023 | Sale | 1,020,000 | 16.61 | 16,942,200 | D |
04 Aug 2023 19:32 | IMGN | ImmunoGen Inc | ENYEDY MARK J | CHIEF EXECUTIVE OFFICER | 04 Aug 2023 | Sale | 992,397 | 16.96 | 16,831,053 | D |
04 Aug 2023 19:33 | IMGN | ImmunoGen Inc | COEN STACY ANN | SVP & CHIEF BUSINESS OFFICER | 04 Aug 2023 | Sale | 80,326 | 17.05 | 1,369,558 | D |
11 Aug 2023 17:02 | IMGN | ImmunoGen Inc | COEN STACY ANN | SVP & CHIEF BUSINESS OFFICER | 09 Aug 2023 | Sale | 100,210 | 14.2 | 1,422,982 | D |
19 Sep 2023 17:27 | IMGN | ImmunoGen Inc | WINGROVE THERESA | SVP OF REGULATORY AFFAIRS | 15 Sep 2023 | Sale | 192,013 | 15.44 | 2,964,681 | D |
18 Oct 2023 16:25 | IMGN | ImmunoGen Inc | WINGROVE THERESA | SVP OF REGULATORY AFFAIRS | 16 Oct 2023 | Sale | 192,004 | 14.4 | 2,764,858 | D |
08 Nov 2023 17:55 | IMGN | ImmunoGen Inc | LENTINI RENEE | VP & PRIN ACCTG OFFICER | 06 Nov 2023 | Sale | 219,545 | 15.29 | 3,356,843 | D |
08 Nov 2023 17:56 | IMGN | ImmunoGen Inc | WINGROVE THERESA | SVP OF REGULATORY AFFAIRS | 07 Nov 2023 | Sale | 19,517 | 16.66 | 325,153 | D |
17 Nov 2023 19:52 | IMGN | ImmunoGen Inc | COEN STACY ANN | SVP & CHIEF BUSINESS OFFICER | 15 Nov 2023 | Sale | 26,286 | 16.01 | 420,839 | D |
17 Nov 2023 19:53 | IMGN | ImmunoGen Inc | WINGROVE THERESA | SVP OF REGULATORY AFFAIRS | 15 Nov 2023 | Sale | 166,725 | 15.85 | 2,642,591 | D |
17 Nov 2023 19:52 | IMGN | ImmunoGen Inc | COEN STACY ANN | SVP & CHIEF BUSINESS OFFICER | 16 Nov 2023 | Sale | 4,100 | 16.01 | 65,641 | D |
17 Nov 2023 19:52 | IMGN | ImmunoGen Inc | COEN STACY ANN | SVP & CHIEF BUSINESS OFFICER | 17 Nov 2023 | Sale | 78,223 | 16.05 | 1,255,479 | D |
01 Dec 2023 19:31 | IMGN | ImmunoGen Inc | WINGROVE THERESA | SVP OF REGULATORY AFFAIRS | 29 Nov 2023 | Sale | 6,792 | 16.66 | 113,155 | D |
05 Dec 2023 21:08 | IMGN | ImmunoGen Inc | COEN STACY ANN | SVP & CHIEF BUSINESS OFFICER | 30 Nov 2023 | Sale | 3,826 | 29.2 | 111,719 | D |
05 Dec 2023 21:06 | IMGN | ImmunoGen Inc | PETERSON KRISTINE | Director | 30 Nov 2023 | Sale | 20,000 | 28.9 | 578,000 | D |
01 Dec 2023 19:31 | IMGN | ImmunoGen Inc | WINGROVE THERESA | SVP OF REGULATORY AFFAIRS | 30 Nov 2023 | Sale | 164,424 | 28.95 | 4,760,075 | D |
19 Dec 2023 18:58 | IMGN | ImmunoGen Inc | WINGROVE THERESA | SVP OF REGULATORY AFFAIRS | 15 Dec 2023 | Sale | 117,445 | 29.4 | 3,452,883 | D |
27 Dec 2023 19:08 | IMGN | ImmunoGen Inc | LENTINI RENEE | VP & PRIN ACCTG OFFICER | 26 Dec 2023 | Sale | 6,548 | 29.74 | 194,738 | D |
18 Jan 2024 18:28 | IMGN | ImmunoGen Inc | WINGROVE THERESA | SVP OF REGULATORY AFFAIRS | 16 Jan 2024 | Sale | 187,667 | 29.64 | 5,562,450 | D |
06 Feb 2024 21:47 | IMGN | ImmunoGen Inc | COEN STACY ANN | SVP & CHIEF BUSINESS OFFICER | 05 Feb 2024 | Sale | 4,583 | 29.3 | 134,282 | D |
06 Feb 2024 21:41 | IMGN | ImmunoGen Inc | LENTINI RENEE | VP & PRIN ACCTG OFFICER | 05 Feb 2024 | Sale | 2,631 | 29.3 | 77,088 | D |
06 Feb 2024 21:42 | IMGN | ImmunoGen Inc | ENYEDY MARK J | CHIEF EXECUTIVE OFFICER | 05 Feb 2024 | Sale | 20,107 | 29.28 | 588,733 | D |
06 Feb 2024 21:43 | IMGN | ImmunoGen Inc | WINGROVE THERESA | SVP OF REGULATORY AFFAIRS | 05 Feb 2024 | Sale | 12,027 | 29.3 | 352,391 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)